Benchimol D - Search Results

1

Contact X-ray therapy for rectal cancer: experience in Centre Antoine-Lacassagne, Nice, 2002-2006.

Gérard JP, Ortholan C, Benezery K, Ginot A, Hannoun-Levi JM, Chamorey E, Benchimol D, François E. Gérard JP, et al. Among authors: benchimol d. Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):665-70. doi: 10.1016/j.ijrobp.2008.01.030. Epub 2008 May 1. Int J Radiat Oncol Biol Phys. 2008. PMID: 18455327

2

Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials.

Ortholan C, Francois E, Thomas O, Benchimol D, Baulieux J, Bosset JF, Gerard JP. Ortholan C, et al. Among authors: benchimol d. Dis Colon Rectum. 2006 Mar;49(3):302-10. doi: 10.1007/s10350-005-0263-x. Dis Colon Rectum. 2006. PMID: 16456638 Review.

3

Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: lessons from a systematic review of recent randomized trials.

Gerard JP, Rostom Y, Gal J, Benchimol D, Ortholan C, Aschele C, Levi JM. Gerard JP, et al. Among authors: benchimol d. Crit Rev Oncol Hematol. 2012 Jan;81(1):21-8. doi: 10.1016/j.critrevonc.2011.02.001. Epub 2011 Mar 5. Crit Rev Oncol Hematol. 2012. PMID: 21377377 Review.

4

[Conservative treatment of epidermoid cancer of the anal canal combining radiotherapy and curietherapy. Experience at the Antoine-Lacassagne Center].

Lagrange JL, Chauvel P, François E, Bourry J, Benchimol D, Bereder JM, Machiavello JC, Richelme H. Lagrange JL, et al. Among authors: benchimol d. Ann Gastroenterol Hepatol (Paris). 1990 Mar-Apr;26(2):45-9. Ann Gastroenterol Hepatol (Paris). 1990. PMID: 2189353 Review. French.

5

Predicting early death in older adults with cancer.

Boulahssass R, Gonfrier S, Ferrero JM, Sanchez M, Mari V, Moranne O, Rambaud C, Auben F, Hannoun Levi JM, Bereder JM, Bereder I, Baque P, Turpin JM, Frin AC, Ouvrier D, Borchiellini D, Largillier R, Sacco G, Delotte J, Arlaud C, Benchimol D, Durand M, Evesque L, Mahamat A, Poissonnet G, Mouroux J, Barriere J, Benizri E, Piche T, Guigay J, Francois E, Guerin O. Boulahssass R, et al. Among authors: benchimol d. Eur J Cancer. 2018 Sep;100:65-74. doi: 10.1016/j.ejca.2018.04.013. Epub 2018 Jun 29. Eur J Cancer. 2018. PMID: 30014882

6

Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: biological and clinical implications.

Italiano A, Saint-Paul MC, Caroli-Bosc FX, François E, Bourgeon A, Benchimol D, Gugenheim J, Michiels JF. Italiano A, et al. Among authors: benchimol d. Ann Oncol. 2005 Sep;16(9):1503-7. doi: 10.1093/annonc/mdi282. Epub 2005 Jun 24. Ann Oncol. 2005. PMID: 15980160 Free article.

7

Cetuximab shows activity in colorectal cancer patients with tumors for which FISH analysis does not detect an increase in EGFR gene copy number.

Italiano A, Follana P, Caroli FX, Badetti JL, Benchimol D, Garnier G, Gugenheim J, Haudebourg J, Keslair F, Lesbats G, Lledo G, Roussel JF, Pedeutour F, François E. Italiano A, et al. Among authors: benchimol d. Ann Surg Oncol. 2008 Feb;15(2):649-54. doi: 10.1245/s10434-007-9667-2. Epub 2007 Nov 7. Ann Surg Oncol. 2008. PMID: 17987340

8

K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.

Etienne-Grimaldi MC, Formento JL, Francoual M, François E, Formento P, Renée N, Laurent-Puig P, Chazal M, Benchimol D, Delpero JR, Letoublon C, Pezet D, Seitz JF, Milano G. Etienne-Grimaldi MC, et al. Among authors: benchimol d. Clin Cancer Res. 2008 Aug 1;14(15):4830-5. doi: 10.1158/1078-0432.CCR-07-4906. Clin Cancer Res. 2008. PMID: 18676755

9

KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications.

Italiano A, Hostein I, Soubeyran I, Fabas T, Benchimol D, Evrard S, Gugenheim J, Becouarn Y, Brunet R, Fonck M, François E, Saint-Paul MC, Pedeutour F. Italiano A, et al. Among authors: benchimol d. Ann Surg Oncol. 2010 May;17(5):1429-34. doi: 10.1245/s10434-009-0864-z. Epub 2010 Jan 5. Ann Surg Oncol. 2010. PMID: 20049644

10

[Advanced cancer of the exocrine pancreas treated by a long-acting luteinising hormone releasing hormone (LH-RH) analogue, triptorelin: phase II study].

François E, Lagrange JL, Benchimol D, Hebuterne X, Montoya ML, Fratini G, Rampal P, Richelme H, Namer M. François E, et al. Among authors: benchimol d. Ann Chir. 1991;45(10):909-11. Ann Chir. 1991. PMID: 1838237 Clinical Trial. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters